Changes in serum lipid profiles caused by three regimens of interferon‐free direct‐acting antivirals for patients infected with hepatitis C virusTakako Inoue, Yasuhito Tanaka, Noboru Shinkai et al.|Hepatology Research|2017Cited by 41
Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assayWai‐Kay Seto, Man‐Fung Yuen, Yasuhito Tanaka et al.|Hepatology International|2012Cited by 41
High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analoguesNoboru Shinkai, Yasuhito Tanaka, Masanori Nojima et al.|Journal of Gastroenterology|2017Cited by 38
Clinical Evaluation of Hepatocarcinogenesis and Outcome Using a Novel Glycobiomarker <i>Wisteria floribunda</i> Agglutinin-Positive Mac-2 Binding Protein (WFA<sup>+</sup>-M2BP) in Chronic Hepatitis C with Advanced FibrosisTakako Inoue, Yasuhito Tanaka, Yuji Tsuzuki et al.|Japanese Journal of Infectious Diseases|2018Cited by 9
[Clinical evaluation of a newly developed high-sensitive detection of hepatitis B virus surface antigen by a semi-automated immune complex transfer chemiluminescent enzyme immunoassay].Kumiko Ohne, Yasuhito Tanaka, Satomi Kani et al.|PubMed|2013Cited by 8